Results 71 to 80 of about 83,313 (237)
Carbamazepine on a carbamazepine monolayer forms unique 1D supramolecular assemblies
High-resolution STM imaging of the structures formed by carbamazepine molecules adsorbed onto a pseudo-ordered carbamazepine monolayer on Au(111) shows the formation of previously unreported 1-dimensional supramolecular ...
Erin V. Iski +9 more
core +1 more source
Dose-dependent metabolism of carbamazepine in humans
48-h steady-state metabolic balance studies were carried out in 17 adults receiving long-term anticonvulsant monotherapy. With increasing carbamazepine dosage (1) carbamazepine overall plasma apparent clearance (CL/F), (2) plasma clearance of ...
Dickinson R.G. +3 more
core +1 more source
Carbamazepine –An oldie but a goodie–A clinician's perspective
Carbamazepine (CBZ) was first reported at much the same time as was sodium valproate (VPA), namely 1962/3 [1]. Unlike VPA, CBZ was not initially reported for the use in epilepsy but rather for the treatment of tic douloureux (trigeminal neuralgia) [1 ...
Beran, RG
core +1 more source
Carbamazepine has become a compound of concern due to its ubiquity, potential toxicity and persistence in surface waters around the world. Carbamazepine is a psychiatric drug used to treat epilepsy, depression, addiction and bipolar disorder. Currently,
Jarvis, Amanda L.
core
Desenvolvimento de microesferas de carbamazepina visando o prolongamento da liberação do fármaco [PDF]
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde. Programa de Pós-Graduação em FarmáciaA carbamazepina (CBZ) é um fármaco anticonvulsivante amplamente empregado no tratamento da epilepsia em doses que variam ...
Zanetti, Betina Giehl
core
Carbamazepine and Erythroid Arrest
A patient who developed anemia with an isolated erythroid toxicity following chronic carbamazepine administration is reported. The anemia quickly resolved with discontinuation of this drug.
Bruce H. Ackerman +2 more
core +1 more source
Epilepsy control with carbamazepine monotherapy from a genetic perspective
Background Ethnicity variation is one of the main factors that may affect drug response in clinical practice. As MTHFR gene affects different transcriptome and proteome which affect the clinical response of drugs.
Shakir Ullah +5 more
doaj +1 more source
Polymorphism in Carbamazepine Cocrystals
Cocrystals of carbamazepine with nicotinamide and saccharin are shown to be polymorphic. Two polymorphs of carbamazepine−nicotinamide (CBZ-NCT) cocrystals and two polymorphs of carbamazepine−saccharin (CBZ-SAC) cocrystals were grown from solution in the ...
William W. Porter III (2460643) +2 more
core +2 more sources
A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012
Background: Carbamazepine has been used as AEDs since 1965, and is most effective against partial seizures. Two basic mechanisms of action have been proposed: 1) enhancement of sodium channel inactivation by reducing high-frequency repetitive firing of ...
Zahra Tolou-Ghamari +3 more
doaj
An 18-year-old woman presented to the emergency department. She had ingested 43 extended-release tablets of carbamazepine 400 mg. Although the patient had high carbamazepine plasma levels and classified as severe intoxication, her clinical symptoms were ...
Heshu Abdullah-Koolmees +4 more
doaj +1 more source

